Printer Friendly

Would you tolerate this abuse?

Americans needlessly die while scientific discoveries that could save their lives remain trapped in bureaucratic red tape.

There is a solution to this travesty. Allow free market innovation into the health care arena, and the development of new medical therapies will progress as rapidly as other technologies.

Do you remember how expensive long distance phone calling used to be?

Back in 1980, archaic federal rules enabled the original AT&T to control national long distance dialing. You could recognize a long distance call by the hissing and crackling noise heard before the caller spoke. Highspeed internet and mobile phone connections were not available.

In 1980, the Life Extension Foundation was in its infancy. Making long distance calls during the day was unaffordable to us. We waited until after 5:00 PM to make brief long distance calls. For calls that involved a lot of talk time, we scheduled these after 11:00 PM (or on weekends) when rates were at their lowest.

By 1982, we needed to install a toll-free "800" line, but feared the high cost. The 50-cent per minute rate caused concern that we might not be able to afford the monthly bill. Factoring in inflation, 50 cents in 1982 is equivalent to $1.16 today. That meant that if our 800 line was used just four hours a day, the monthly cost would be $6,960 in today's dollars.


There was quite a debate around 1980 as to whether consumers would benefit if other companies were allowed to compete in offering long distance services. AT&T heavily lobbied Congress arguing that all kinds of terrible problems would occur if it lost its monopoly.


AT&T pointed to its stellar record of scientific advances and threatened that if it could not charge its monopolistic rates, then further improvements in communications technology would be hindered. AT&T's track record for scientific prowess gave them a strong argument.

Fortunately, free market theory prevailed and AT&T was forced to relinquish its stranglehold over long distance calling in the United States. The transition was by no means smooth. The initial long distance competitors' services were clearly inferior to AT&T. We at Life Extension found it frustrating to initiate long distance calls over these discount carriers' networks. One newspaper columnist complained that he was tired of being solicited by these substandard discount carriers and wanted the government to reinstate AT&T's monopoly.


Anyone who has paid attention to long distance rates over the past 28 years appreciates the enormity of the benefit brought about by abolishing AT&T's monopoly.


Consumers used to pay over 60 cents per minute for daytime long distance calls (equal to $1.39 per minute in today's depreciated dollars). (1) Can you imagine if you had to pay $250 for three hours of long distance calling? This would be unthinkable today where for under $40 a month, you can have an unlimited long distance service that usually includes local connection charges.

Consumers today save a whopping 84% compared with 1980, even if they only make three hours of long distance calls a month. Unlike AT&T's threats of technological stagnation, the quality, reliability, and speed of today's long distance phone service are vastly superior.

As far as Life Extension's toll free service, our rate has dropped to 1.6 cents per minute. Back in 1982, we were paying the equivalent in today's dollars of $1.16 per minute for inferior service. When adjusted for inflation, we are saving 99% compared with what we paid in 1982.


What if the federal government outlawed long distance competition and returned to the monopolistic ways of the past? If this were to occur, I am certain that every elected politician (who voted for this) would be thrown out of office.

Yet the public today tolerates federal and state laws that enable pharmaceutical companies to conduct business as a virtual monopoly. The result is that Americans pay outlandish prices for mediocre drugs that are often laden with side effects.


As AT &T did in 1980, drug companies seek to deceive Congress and the public by stating their high prices are needed in order to discover better technologies. The reality is that after decades of exorbitant drug pricing, one's odds of surviving a serious disease using conventional methods are not substantially improving. Yet drug prices are exponentially higher.

Citizen apathy has allowed this economic and medical bloodbath to occur. One of Life Extension's missions is to provide the hard facts so that today's antiquated regulatory system can be eradicated. We believe that in a free market environment, technological breakthroughs that occurred in telecommunications will also happen in medicine.


Unlike regulated prescription drugs, the cost of dietary supplements has plummeted over the past three decades.

For example, when coenzyme Q10 (CoQ10) was first introduced to Americans in 1983, a bottle containing 1,000 mg (100 10-mg capsules) retailed for $30. In 2008, the retail price of a bottle containing 5,000 mg (100 50-mg capsules) of a superior form of CoQ10 (ubiquinol) is $58. Based on milligram potency alone, the cost in inflation-adjusted dollars for CoQ10 has come down by 83%.

If the FDA had succeeded in turning CoQ10 into a drug as it tried to do in the early 1980s, you might be paying $337.50 for what retails now for $58 (and costs Life Extension members far less).

Under the FDA's regulatory stranglehold, it is unlikely that the superior ubiquinol form of CoQ10 would have been "approved" any time soon. This would force Americans to pay the inflated price ($337.50 per bottle) for a less-than-optimal product. This illogic is what monopolies are all about, and why they cannot be allowed to exist.


If one looks at the price history of dietary supplements, costs are substantially lower now than when they were originally brought out. When SAMe was first introduced to Americans in 1996, it cost $45 for 4,000 mg (20 200-mg tablets). This was the European-regulated "drug" price. Soon after it became an unregulated supplement, the price went down a great deal. As more manufacturers competed to make SAMe, the price plummeted to where Life Extension members can obtain 8,000 mg (20 400mg tablets) for only $21. Thus SAMe now costs 77% less than when it was originally introduced.

Prescription drug costs, on the other hand, have skyrocketed at a rate that far exceeds inflation. The difference is that prescription drugs are heavily regulated, as opposed to dietary supplements that are sold under free market conditions.

I accumulate so many reports about today's health care calamities that it is not possible to fit them into one issue of Life Extension magazine. To remind you of recent findings, we have reprinted a few of the appalling headlines. (2-10)

As you can clearly see by these reports, unless radical legal changes are made, Americans will continue to pay high prices for dangerous drugs that have limited efficacy.

More frightening is the suffocating effect that regulation has on the discovery of life-saving therapies. Just imagine if advancement in clinical medicine progressed at the same rapid rate as telecommunications. If it did, we would probably have cures for most killer diseases today!

For example, the first direct-dial transcontinental telephone call occurred in 1951. (11) That first call took 18 seconds to complete, had lots of static in the background, and most consumers could not readily afford it. Move forward to 2008, and we all have access to clear phone connections across the country instantly at minimal cost.

Now look at the dire prognosis for pancreatic cancer patients today. A patient diagnosed with pancreatic cancer in 2008 typically lives just a few months longer compared with 1951. (12-14) Yet the price for these additional months of life can be thousands of times higher than that in 1951. (15)

We need to swiftly improve medical science at a speed analogous to telecommunications, computers, and other unregulated technologies.


The FDA has provided a rare opportunity to enact legislation that can enable Americans to quickly gain access to life-saving medical therapies.


As reported two months ago in my article "The FDA Indicts Itself," the FDA did a study of itself and its findings revealed that it is scientifically incompetent and incapable of doing its job. (16,17) These are not mere allegations from outside critics, but are instead the FDA itself admitting that it cannot carry out its mission.

There has never been a better time for a comprehensive overhaul of the FDA. Everything about it--from its mission to its management--needs to be taken apart, reviewed, redefined, and recreated so that it helps support, rather than obstruct, a vibrant free market in health care science.


I am pleased to announce that the American Association for Health Freedom, an organization committed to complete reform of the FDA, is spearheading a campaign to change today's broken system. (18) This is not our organization, but one that represents a coalition of integrative physicians, health care consumers, and health freedom activists around the country.

The approach that the American Association for Health Freedom is proposing will enable Americans to access affordable, safe, and effective therapies that are being denied to them now.

We at Life Extension are proud to be a sponsor of the American Association for Health Freedom and join other visionary leaders who support it.


There are pessimists who think Americans will not be able to achieve true health freedom in the immediate future. Naysayers complain that if free market principles are extended to health care, some terminally ill patients will die sooner if experimental therapies fail.

My response is to again analogize what happened when long distance phone calling was deregulated. Sure, there were problems in the beginning, but look at where we are today with a dependable low-cost phone service affordable to all. Even more impressive are the incredible advancements in high-speed internet access and mobile phone connectivity that would have been unthinkable in the early 1980s.

A lot of my enthusiasm for a free market approach to health care is based on my own confidence in judging which novel medical therapies are truly safe and effective. A look at Life Extension's 28-year track record shows that we have been able to identify life-saving approaches to combating disease long before they are approved by the FDA.

Have we made mistakes? Yes, we have fallen victim to a few fraudulent studies that caused us to recommend products that we later found did not work. We have not, however, recommended products that killed anyone. Contrast this to regulated FDA-approved drugs that have collectively killed millions of Americans over the past three decades.

I believe the logic of letting the free market determine what therapies Americans may use to prevent and treat disease will defeat the cynics who fear changing the regulatory quagmire that exists today. Existing laws that protect against real health fraud will still enable charlatans to be stopped and prosecuted.


For those who don't know the history of the Life Extension Foundation, we have battled bureaucratic ineptitude since the early 1980s. Our overriding motivation is the fact that our very lives are at stake if we fail to abolish today's obsolete regulation of our health care.

One of our victories was the passage of the Dietary Supplement Health and Education Act (DSHEA). (19) This legislation enabled consumers to learn about some of the benefits of dietary supplements. When the DSHEA legislation was initially proposed, it was apathetically viewed and most people thought it could never be enacted.

It took five years to pass DSHEA, but we eventually rallied so many consumers and industry leaders that Congress passed this landmark legislation. Please know that Life Extension was not the only one responsible for passage of DSHEA. Our support at its embryonic stage, however, set the stage for DSHEA to evolve from an obscure snowball in 1989 to an unstoppable avalanche in 1994.

It is now time again to educate Congress about the urgent need to reform the FDA. I plan to use the enormous success of long distance phone deregulation to help persuade the public and Congress that today's health care cost crisis will largely disappear if we return to free market principles in health care.


To persuade Congress to address this monumental problem, a Petition to Reform the FDA has been drafted.

Our first mission is to collect so many names on the Reform FDA Petition that it compels Congressional action. We will hand deliver the Petition to Congressional leaders and urge them to enact comprehensive FDA reform.

I ask every Life Extension member to put their name on this Petition so that Congress knows the citizenry is behind this groundbreaking initiative.

The easiest way to sign the Reform FDA Petition is to do so online. This new website has been set up by the American Association for Health Freedom (AAHF), an independent non-profit organization committed to the total overhaul of the FDA.

For longer life,

William Faloon


(1.) Consumer Reports. 1983. Nov;48(11): 618-20.

(2.) Available at: 2008/03/03/news/economy/ 104239768.fortune/index.htm. Accessed June 23, 2008.

(3.) Available at: Accessed June 23, 2008.

(4.) Available at: children.drug.errors.ap/index.html. Accessed June 23, 2008.

(5.) Available at: articles/ 2007/08/11/us_life_span_shorter/. Accessed June 23, 2008.

(6.) Available at: fda/index.htm. Accessed June 23, 2008.

(7.) Available at: our-view-on-exp.html. Accessed June 23, 2008.

(8.) Available at:,2933,296427,00.html. Accessed June 23, 2008.

(9.) Available at: Accessed June 23, 2008.

(10.) Available at: kmov_health_071008_breastcancerheart.14e95c1d0.html. Accessed June 23, 2008.

(11.) Available at: timeline/51trans.html. Accessed June 23, 2008.

(12.) Stewart RJ, Stewart AW, Stewart JM, Ibister WH. Cancer of the pancreas in New Zealand 1970-1974. Aust N Z J Surg. 1982 Aug;52(4):379-84.

(13.) Available at: %20Media%20Sheet.pdf. Accessed June 26, 2008.

(14.) Czernichow P, Lerebours E, Colin R. Epidemiology of cancer of the pancreas. Current data. Presse Med. 1986 Feb 22;15 (8):387-91.

(15.) Available at: Accessed June 26, 2008.

(16) Faloon W. The FDA indicts itself. Life Extension. 2008 July;14(7):7-11.

17. Available at: briefing/2007-4329b_02_01_FDA%20Report%20on%20Science% 20and%20Technology.pdf. Accessed June 23, 2008.

(18.) Available at: Accessed June 23, 2008.

(19.) Available at: Accessed June 23, 2008.
COPYRIGHT 2008 LE Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:AS WE SEE IT
Author:Faloon, William
Publication:Life Extension
Geographic Code:1USA
Date:Sep 1, 2008
Previous Article:Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial.
Next Article:Headline quotes reveal just a few examples of today's health care crisis.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |